F Isnard

1.8k total citations
43 papers, 966 citations indexed

About

F Isnard is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, F Isnard has authored 43 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 13 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in F Isnard's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (8 papers). F Isnard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (8 papers). F Isnard collaborates with scholars based in France, Belgium and Switzerland. F Isnard's co-authors include L Fouillard, Sylvie Lesage, A Najman, J Stachowiak, Luc Douay, J.P. Laporte, NC Gorin, Myriam Labopin, J R Laporte and Norbert Claude Gorin and has published in prestigious journals such as The Lancet, Blood and Clinical Pharmacology & Therapeutics.

In The Last Decade

F Isnard

41 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Isnard France 20 490 289 237 168 144 43 966
Morio Sawamura Japan 17 453 0.9× 235 0.8× 295 1.2× 73 0.4× 159 1.1× 86 1.0k
Claire Oudin France 21 550 1.1× 193 0.7× 277 1.2× 135 0.8× 46 0.3× 39 1.1k
Naohito Fujishima Japan 19 598 1.2× 326 1.1× 167 0.7× 133 0.8× 108 0.8× 63 1.4k
Kazuhiko Kakihana Japan 18 605 1.2× 284 1.0× 420 1.8× 152 0.9× 42 0.3× 77 1.2k
Vincenzo Poggi Italy 19 345 0.7× 72 0.2× 223 0.9× 111 0.7× 53 0.4× 44 1.1k
A. C. Newland United Kingdom 20 439 0.9× 329 1.1× 179 0.8× 382 2.3× 136 0.9× 57 1.3k
D. L. Barnard United Kingdom 15 205 0.4× 120 0.4× 103 0.4× 157 0.9× 106 0.7× 31 657
Lorraine Pall United States 10 352 0.7× 238 0.8× 40 0.2× 89 0.5× 134 0.9× 11 924
Guillermo Ortí Spain 12 364 0.7× 226 0.8× 113 0.5× 128 0.8× 58 0.4× 32 849
J Sheskin Israel 12 420 0.9× 82 0.3× 221 0.9× 98 0.6× 47 0.3× 43 893

Countries citing papers authored by F Isnard

Since Specialization
Citations

This map shows the geographic impact of F Isnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Isnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Isnard more than expected).

Fields of papers citing papers by F Isnard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Isnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Isnard. The network helps show where F Isnard may publish in the future.

Co-authorship network of co-authors of F Isnard

This figure shows the co-authorship network connecting the top 25 collaborators of F Isnard. A scholar is included among the top collaborators of F Isnard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Isnard. F Isnard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guitard, J., F Isnard, Marie‐Dominique Tabone, et al.. (2018). Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients. Journal of Infection. 76(5). 483–488. 19 indexed citations
2.
Barranger, Emmanuel, F Isnard, Alexandre Bricou, Émile Daraï, & Yann Delpech. (2012). Colpohystérectomie élargie par voie cœlioscopique dans les cancers du col utérin : étude de qualité de vie. À propos de 22 cas. Gynécologie Obstétrique & Fertilité. 40(10). 572–577. 1 indexed citations
3.
Itzykson, Raphaël, Sylvain Thépot, Odile Beyne‐Rauzy, et al.. (2011). Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?. Leukemia Research. 36(4). 397–400. 9 indexed citations
4.
Maertens, J, Raoul Herbrecht, Maja Weisser, et al.. (2010). A retrospective series of gut aspergillosis in haematology patients. Clinical Microbiology and Infection. 17(4). 588–594. 52 indexed citations
5.
6.
Yeshurun, Moshe, L Fouillard, Myriam Labopin, et al.. (2004). A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant. Leukemia. 18(10). 1717–1721. 3 indexed citations
7.
Coppo, Paul, Malek Aoudjhane, Pierre Lebon, et al.. (1999). Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplantation. 23(4). 401–403. 30 indexed citations
8.
Smadja, N, F Isnard, Christophe Louvet, et al.. (1998). Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. Leukemia. 12(6). 960–969. 133 indexed citations
9.
Morel, Pierre, Luc Douay, L Fouillard, et al.. (1995). Autologous bone marrow transplantation as consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: a pilot study of 34 cases.. PubMed. 9(4). 576–82. 30 indexed citations
10.
Isnard, F, et al.. (1995). [North American contribution to the metformin dossier].. PubMed. 293–311. 1 indexed citations
11.
Najman, A, et al.. (1993). [Effects of the tetrapeptide AcSDKP on normal and leukemic bone marrow].. PubMed. 35(3). 279–80. 2 indexed citations
12.
Laporte, J.P., F Isnard, Sylvie Lesage, et al.. (1993). Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study.. PubMed. 7(12). 2030–3. 26 indexed citations
13.
Gorin, Norbert Claude, J.P. Laporte, Myriam Labopin, et al.. (1991). Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation. European Journal Of Haematology. 47(5). 346–354. 62 indexed citations
14.
Fouillard, L, Norbert Claude Gorin, J.P. Laporte, et al.. (1991). Feasibility of autologous bone marrow transplantation for early consolidation of follicular non‐Hodgkin's lymphoma. European Journal Of Haematology. 46(5). 279–284. 29 indexed citations
15.
Laporte, J.P., L Fouillard, F Isnard, et al.. (1991). GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen. The Lancet. 338(8767). 601–602. 33 indexed citations
16.
Isnard, F, et al.. (1991). [Glycemic equilibrium and weight evolution in diabetics taking metformin].. PubMed. 297–314. 3 indexed citations
17.
Fouillard, L, et al.. (1991). [Autologous bone marrow graft in the initial treatment of follicular lymphomas in young high risk subjects. A new therapeutic approach].. PubMed. 20(27). 1259–64. 2 indexed citations
18.
Laporte, J.P., Luc Douay, Manuel López, et al.. (1990). Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. British Journal of Haematology. 74(4). 445–451. 7 indexed citations
19.
Lacomblez, Lucette, Gilbert Bensimon, F Isnard, et al.. (1989). Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clinical Pharmacology & Therapeutics. 45(3). 241–251. 38 indexed citations
20.
Fouillard, L, Marjan van den Akker, J.P. Laporte, et al.. (1989). [Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development].. PubMed. 18(36). 1785–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morio Sawamura Breakdown of academic impact, for papers by Claire Oudin Breakdown of academic impact, for papers by Naohito Fujishima Breakdown of academic impact, for papers by Kazuhiko Kakihana Breakdown of academic impact, for papers by Vincenzo Poggi Breakdown of academic impact, for papers by A. C. Newland Breakdown of academic impact, for papers by D. L. Barnard Breakdown of academic impact, for papers by Lorraine Pall Breakdown of academic impact, for papers by Guillermo Ortí Breakdown of academic impact, for papers by J Sheskin
Rankless by CCL
2026